---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-003010"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2023-05-08T23:59:59+00:00"
generated_at: "2026-06-15T13:50:24.224578+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals appoints Bettina Cockroft, M.D., M.B.A. to Board of Directors

## Summary
- Appointed Bettina Cockroft as independent director effective May 3, 2023; no committee assignments at this time.
- Granted ten-year option for 8,300 shares at $1.67, vesting monthly over 36 months.
- Cockroft is SVP/CMO of Sangamo Therapeutics, with over 30 years biopharma experience.
- Standard non-employee director compensation applies, as described in prior SEC filings.

## SEC filing metadata
- accession: 0001683168-23-003010
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2023-05-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316823003010/0001683168-23-003010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316823003010/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-003010
- JSON: https://secwatch.observer/filing/0001683168-23-003010.json
- Plain text: https://secwatch.observer/filing/0001683168-23-003010.txt

## Key facts
- Executive change
  Bettina M. Cockroft was appointed as Independent Director at CNS Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Independent Director
  source text: On May 3, 2023, the Board of Directors of CNS Pharmaceuticals, Inc. (the “Company”) appointed Bettina M. Cockroft, M.D., M.B.A as an independent member of the Company’s Board of Directors effective on such date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1729427/000168316823003010/0001683168-23-003010-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.